Selected publications
-
Reply to R.L. Nussbaum et al and J.S. Dolinsky et al.
Journal of Clinical Oncology.
2017
Academic Article
GET IT
Times cited: 1 -
Response.
Journal of the National Cancer Institute.
2016
Academic Article
GET IT
Times cited: 1 -
A recurrent ERCC3 truncating mutation confers moderate risk for breast cancer.
Cancer Discovery.
2016
Academic Article
GET IT
Times cited: 14 -
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study.
European Urology.
2014
Academic Article
GET IT
Times cited: 119 -
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction.
Cancer Research.
2010
Academic Article
GET IT
Times cited: 132 -
Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: An update.
Breast Cancer Research and Treatment.
2009
Academic Article
GET IT
Times cited: 20 -
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
Journal of the National Cancer Institute.
2008
Academic Article
GET IT
Times cited: 127 -
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
International Journal of Cancer.
2008
Academic Article
GET IT
Times cited: 237 -
Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Research and Treatment.
2007
Academic Article
GET IT
Times cited: 40 -
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A Consortium of Investigators of Modifiers of BRCA1/2 study.
Cancer Epidemiology Biomarkers and Prevention.
2007
Academic Article
GET IT
Times cited: 26 -
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
The Lancet Oncology.
2007
Academic Article
GET IT
Times cited: 185